Search

everythinglearnresearchcommunity

for

Search:↓

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

A woman experienced unusual hair loss and skin reactions after taking phenobarbital, but her hair grew back after treatment.

The new gel formulation effectively delivers Finasteride for hair growth treatment without skin irritation.

A new compound was made that might help treat diseases related to male hormones.

Andrographolide-loaded topical nanocarriers are a safe and effective treatment for psoriasis.

Intralesional steroids are the most effective treatment for alopecia areata.

Researchers created a new method to measure brain steroids, finding higher levels of certain steroids and changes due to a drug.

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

Nanofat injections can significantly improve hair growth in men with hair loss for up to a year.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Low-dose naltrexone may help reduce redness in certain scalp conditions.

Plant-derived nanovesicles effectively deliver finasteride for hair regrowth in androgenetic alopecia.

DNCB is more effective than betamethasone for hair regrowth but has more side effects.

Low-dose oral naltrexone may help reduce inflammation in some scarring alopecia patients.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.

The new treatment using tiny lipid carriers to deliver minoxidil and latanoprost directly to hair follicles shows promise for alopecia.

The new nitric oxide delivery system may effectively treat hair loss by improving hair follicle health and reducing inflammation.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

DPCP may be safe for treating alopecia during pregnancy, but more research is needed.

Microneedle delivery of platelet-rich plasma may be slightly better for hair regrowth than intradermal injection.

Polymeric micelle nanocarriers deliver adapalene more effectively to hair follicles than commercial products.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

ACA from Alpinia galanga may prevent testosterone-related hair loss.

PDLLA scalp injections improved hair regrowth in most patients with non-scarring alopecia.

A combination of nanomilled oral testosterone and dutasteride normalized testosterone levels in men with low testosterone and is safe for short-term use.